Jane Street’s BIOATLA INC BCAB Stock Holding History

Jane Street’s Portfolio BCAB Stock Details BCAB Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	–	Sell	-1,404	Closed	-$11.3K	–	11549
2026 Q1	$11.3K	Buy	+1,404	New	+$16.4K	﹤0.01%	11293
2025 Q4	–	Sell	-576	Closed	-$19.8K	–	11114
2025 Q3	$19.8K	Buy	+576	New	+$13.3K	﹤0.01%	10535

Other funds holding BCAB

ACA

Acorn Capital Advisors New York $366M AUM 474.6% 1-Year Est. Return

Millennium Management New York $276B AUM 44.8% 1-Year Est. Return

Lido Advisors Los Angeles, California $36.8B AUM 26.6% 1-Year Est. Return

SCM

Stonepine Capital Management Bend, Oregon $177M AUM 91.13% 1-Year Est. Return

Acadian Asset Management Boston, Massachusetts $84.2B AUM 55.88% 1-Year Est. Return

HRT Financial New York $54.8B AUM 81.03% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Deutsche Bank Frankfurt Am Main Ge, Germany $344B AUM 42.99% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

Jane Street's BCAB Position: Q2 2026 in Review

Jane Street sold out of BIOATLA INC (BCAB) in Q2 2026, closing a stake of 463 shares — an estimated $3.73K sold.

Jane Street first reported a position in BCAB in Q1 2021 and held it in 17 quarters. The position peaked at $461K in Q4 2022. 21 funds tracked by Wall St. Rank hold BCAB as of Q2 2026.

Jane Street reported no remaining BIOATLA INC position as of Q2 2026 after selling out during the quarter.
Jane Street sold 463 BIOATLA INC shares in Q2 2026, an estimated $3.73K.
Jane Street first reported a position in BIOATLA INC in Q1 2021 and held it in 17 quarters.
Jane Street's BIOATLA INC position peaked at $461K in Q4 2022.
21 funds tracked by Wall St. Rank held BIOATLA INC as of Q2 2026.

Based on Jane Street's 13F filing for Q2 2026, filed 14 Aug 2026.